Radiofrequency-Induced Thermo-Chemotherapy Effect (Rite) for Non Muscle Invasive Bladder Cancer Treatment: Current Role and Perspectives

2016 ◽  
Vol 83 (2_suppl) ◽  
pp. 7-17 ◽  
Author(s):  
Renzo Colombo ◽  
Hans van Valenberg ◽  
Marco Moschini ◽  
Johannes A. Witjes
Keyword(s):  
Bladder Cancer ◽  
Cancer Treatment ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Current Role ◽  
Muscle Invasive

scholarly journals The current role of circulating biomarkers in non-muscle invasive bladder cancer

2019 ◽  
Vol 8 (1) ◽  
pp. 61-75 ◽  
Author(s):  
Michael Rink ◽  
◽  
Heidi Schwarzenbach ◽  
Malte W. Vetterlein ◽  
Sabine Riethdorf ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Circulating Biomarkers ◽  
Muscle Invasive Bladder Cancer ◽  
Current Role ◽  
Muscle Invasive

The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients

2018 ◽  
Vol 9 (5) ◽  
pp. 507-512 ◽  
Author(s):  
Marco Racioppi ◽  
Luca Di Gianfrancesco ◽  
Mauro Ragonese ◽  
Giuseppe Palermo ◽  
Emilio Sacco ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Cancer Treatment ◽  
Older Patients ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Bcg Therapy ◽  
Muscle Invasive

Intravesical Thalidomide boosts bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer treatment

2017 ◽  
Vol 35 (1) ◽  
Author(s):  
Gabriela R. Passos ◽  
Juliana A. Camargo ◽  
Karen L. Ferrari ◽  
Mário J. A. Saad ◽  
Amilcar C. de Mattos ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Treatment ◽  
Invasive Bladder Cancer ◽  
Bacillus Calmette Guerin ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive

scholarly journals Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians

2021 ◽  
Author(s):  
Aleksander Ślusarczyk ◽  
Karolina Garbas ◽  
Piotr Zapała ◽  
Łukasz Zapała ◽  
Piotr Radziszewski
Keyword(s):  
Bladder Cancer ◽  
Cancer Treatment ◽  
Charlson Comorbidity Index ◽  
Invasive Bladder Cancer ◽  
High Grade ◽  
Muscle Invasive Bladder Cancer ◽  
Oncological Outcomes ◽  
Bcg Therapy ◽  
Comorbidity Index ◽  
Muscle Invasive

Abstract Purpose To evaluate the outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment (NMIBC) in elderly patients over 80 years of age. Methods This is a retrospective single tertiary-centre study. Medical records of patients with T1 high-grade NMIBC treated with transurethral resection of the bladder tumour (TURBT) were reviewed. Among 269 patients with high-grade T1 NMIBC, 74 individuals were over 80 years of age at the time of surgery. Finally, 67 patients met the inclusion criteria. Results Only 47.8% of patients (N = 32) received at least five of the six instillations of the BCG immunotherapy induction course. Oncological outcomes were compared between patients who received at least the induction course of BCG and non-BCG-treated patients matched to each other based on age and Charlson comorbidity index. Thirty case–control pairs were included in the final analysis. Rates of disease recurrence (80% vs. 53%) and cancer-specific mortality (40% vs. 10%) were significantly higher in the group of patients who did not receive BCG. BCG therapy, Charlson comorbidity index, haemoglobin concentration and the number of tumours > 3 in TURBT constituted independent prognostic factors for cancer-specific survival (CSS). Conclusion BCG should be strongly recommended to patients with T1HG NMIBC despite advanced age and comorbidities. Already BCG induction improves CSS and reduces the recurrence rate in octogenarians with T1HG bladder cancer.

SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer

2019 ◽  
Vol 37 (1) ◽  
pp. 61-83 ◽  
Author(s):  
Jeffrey J. Leow ◽  
Jens Bedke ◽  
Karim Chamie ◽  
Justin W. Collins ◽  
Siamak Daneshmand ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Treatment ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Muscle Invasive
Sign in / Sign up

Export Citation Format

Share Document